Paula Jean Marks

Title: The Innovations of Paula Jean Marks

Introduction

Paula Jean Marks is a notable inventor based in Maynard, MA (US). She has made significant contributions to the field of biomedical research, particularly in the detection and quantification of neu-related proteins in human biological fluids. Her work has implications for understanding various health conditions and advancing medical diagnostics.

Latest Patents

Paula Jean Marks holds 1 patent for her invention titled "Detection and quantification of neu related proteins in the biological fluids of humans." This invention focuses on a substantially purified p100, a human neu-related protein with a molecular weight ranging from about 97,000 daltons to about 115,000 daltons. This protein corresponds to the extracellular domain of the human neu gene product and is detectable in biological fluids. Additionally, her invention includes assays for detecting this protein and monoclonal antibodies capable of binding to p100.

Career Highlights

Paula has built a successful career at Bayer Corporation, where she has been able to apply her expertise in protein detection and analysis. Her innovative work has contributed to advancements in medical research and diagnostics, showcasing her commitment to improving healthcare outcomes.

Collaborations

Throughout her career, Paula has collaborated with esteemed colleagues, including Walter P. Carney and Gail P. Mazzara. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Paula Jean Marks is a pioneering inventor whose work in the detection of neu-related proteins has the potential to transform medical diagnostics. Her contributions to Bayer Corporation and collaborations with fellow researchers highlight her dedication to advancing the field of biomedical research.